GIDEON LADD: Open Payments
NPI 1225061906 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 6 payments from 6 companies in 2025. Trend: 2023 $414 · 2024 $255 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $51 |
| W. L. Gore & Associates, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| HEARTFLOW, INC. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $4 |
Products named: SAPIEN 3 Ultra RESILIA, GORE EXCLUDER AAA Endoprosthesis, LEQVIO, FFRct, FARXIGA, LifeVest.
Industry payments across GA — which companies pay providers there.
